{"entity":{"type":"insider","cik":"0001742266","url":"/insider/0001742266","json_url":"/insider/0001742266.json","name":"Barber Daniel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2018-12-10","last":"2026-08-18","span_basis":"filed_date"},"name_variants":[{"name":"Barber Daniel","source":"filing","n_filings":10,"first_seen":"2018-12-10","last_seen":"2026-08-18"}],"transactions":[{"id":9273656,"accession":"0001214659-26-010516","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-010516","line_url":"/filing/0001214659-26-010516#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":4.2867,"price_display":"4.29","price_state":"stated","total_value":107167.5,"total_display":"107,167.50","total_whole":"107,168","shares_owned_after":585574.0,"shares_owned_after_display":"585,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-18","scope":"insider"},{"id":6090102,"accession":"0001214659-26-008663","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-26-008663","line_url":"/filing/0001214659-26-008663#line-2","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20369.0,"shares_display":"20,369","price_per_share":4.0016,"price_display":"4.00","price_state":"stated","total_value":81508.5904,"total_display":"81,508.59","total_whole":"81,509","shares_owned_after":610574.0,"shares_owned_after_display":"610,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-16","filed_date":"2026-07-17","scope":"insider"},{"id":6090092,"accession":"0001214659-26-008663","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-008663","line_url":"/filing/0001214659-26-008663#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4631.0,"shares_display":"4,631","price_per_share":4.0344,"price_display":"4.03","price_state":"stated","total_value":18683.3064,"total_display":"18,683.31","total_whole":"18,683","shares_owned_after":630943.0,"shares_owned_after_display":"630,943","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-15","filed_date":"2026-07-17","scope":"insider"},{"id":6074098,"accession":"0001214659-26-007511","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-007511","line_url":"/filing/0001214659-26-007511#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":4.1604,"price_display":"4.16","price_state":"stated","total_value":104010.0,"total_display":"104,010.00","total_whole":"104,010","shares_owned_after":635574.0,"shares_owned_after_display":"635,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-16","scope":"insider"},{"id":5851044,"accession":"0001214659-26-006532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-26-006532","line_url":"/filing/0001214659-26-006532#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8257.0,"shares_display":"8,257","price_per_share":4.2889,"price_display":"4.29","price_state":"stated","total_value":35413.4473,"total_display":"35,413.45","total_whole":"35,413","shares_owned_after":660574.0,"shares_owned_after_display":"660,574","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-18","scope":"insider"},{"id":6117996,"accession":"0001214659-26-003146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-26-003146","line_url":"/filing/0001214659-26-003146#line-2","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Officer (President and CEO)","role_mark":"O","role_mark_label":"Officer (President and CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180677.0,"shares_display":"180,677","price_per_share":4.173,"price_display":"4.17","price_state":"stated","total_value":753965.121,"total_display":"753,965.12","total_whole":"753,965","shares_owned_after":1004753.0,"shares_owned_after_display":"1,004,753","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-10","filed_date":"2026-03-11","scope":"insider"},{"id":4273142,"accession":"0001214659-25-014288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-014288","line_url":"/filing/0001214659-25-014288#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":91343.0,"shares_display":"91,343","price_per_share":6.0343,"price_display":"6.03","price_state":"stated","total_value":551191.0649,"total_display":"551,191.06","total_whole":"551,191","shares_owned_after":923430.0,"shares_owned_after_display":"923,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-26","filed_date":"2025-09-29","scope":"insider"},{"id":4094799,"accession":"0001214659-25-014009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-25-014009","line_url":"/filing/0001214659-25-014009#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":2400.0,"total_display":"2,400.00","total_whole":"2,400","shares_owned_after":1014773.0,"shares_owned_after_display":"1,014,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-19","filed_date":"2025-09-22","scope":"insider"},{"id":6190033,"accession":"0001628280-22-016876","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-016876","line_url":"/filing/0001628280-22-016876#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Officer (Chief Executive Officer)","role_mark":"O","role_mark_label":"Officer (Chief Executive Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":91743.0,"shares_display":"91,743","price_per_share":0.96,"price_display":"0.96","price_state":"stated","total_value":88073.28,"total_display":"88,073.28","total_whole":"88,073","shares_owned_after":193702.0,"shares_owned_after_display":"193,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-08","filed_date":"2022-06-10","scope":"insider"},{"id":8325777,"accession":"0001214659-19-005489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-19-005489","line_url":"/filing/0001214659-19-005489#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Officer (SVP-Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (SVP-Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP-Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.99,"price_display":"3.99","price_state":"stated","total_value":7980.0,"total_display":"7,980.00","total_whole":"7,980","shares_owned_after":101959.0,"shares_owned_after_display":"101,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-08-27","scope":"insider"},{"id":6135234,"accession":"0001140361-18-044868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-18-044868","line_url":"/filing/0001140361-18-044868#line-1","is_derivative":false,"issuer_cik":"0001398733","issuer_name":"Aquestive Therapeutics, Inc.","issuer_ticker":"AQST","issuer_name_source":null,"issuer_url":"/issuer/0001398733","owner_cik":"0001742266","owner_name":"Barber Daniel","owner_display_name":"Barber Daniel","owner_url":"/insider/0001742266","role":"Officer (SVP-Chief Strategy/Dev Officer)","role_mark":"O","role_mark_label":"Officer (SVP-Chief Strategy/Dev Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP-Chief Strategy/Dev Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","total_whole":"8,000","shares_owned_after":99959.0,"shares_owned_after_display":"99,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001398733","name":"Aquestive Therapeutics, Inc.","url":"/issuer/0001398733","role":"Director, Officer (President and CEO)","n_filings":10,"first_seen":"2018-12-10","last_seen":"2026-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001742266","retrieved_at":"2026-08-27T09:16:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}